Mount Sinai expands cutting-edge molecul...( Today Mount Sinai Hospital announced ...),Health

Today, Mount Sinai Hospital, announced that it has signed a three-year strategic alliance agreement with world-renowned diagnostic company Roche Diagnostics, to establish a Molecular Center of Excellence (MCOE). As a Roche designated MCOE, the Molecular Pathology Laboratory will offer physicians and patients the most advanced molecular diagnostics technologies such as Roche Diagnostics' patented Polymerase Chain Reaction (PCR), which is more sensitive and more specific than traditional diagnostic methods such as culture.

The Molecular Pathology Laboratory at Mount Sinai, through the leadership of Dr. David Zhang, has become nationally recognized for excellence in technology-based research and clinical molecular diagnostics. More than 6,000 medical laboratory tests are performed each year including 1) tests for infectious agents, such as Human Papiloma Virus and Epstein-Barr virus; 2) tests for genetic disorders, such as Factor V Leiden and Factor II (Prothrombin) gene mutation tests that provide fast and accurate tools to aid in the diagnosis and evaluation of patients with suspected thrombophilia; and 3) tumor oncology assays, such as tests for certain lymphocyte gene rearrangement which act as diagnostic markers for certain lymphomas and leukemias. These tests and other molecular diagnostics tests performed at Mount Sinai allow physicians to diagnose, treat and monitor diseases but most importantly, improve the lives of many patients seen at Mount Sinai.

"We are very excited to partner with Roche Diagnostics, a leader in the diagnostics industry," said David Zhang, MD, PhD, director of the Molecular Pathology Laboratory at Mount Sinai. "With the combination of Roche's cutting edge technologies and our expertise in clinical molecular diagnosis, we will be able to offer the most advanced diagnostic testing to Mount Sinai clinicians to assist with diagnosis, prescription and prognosis. The Molecular Pathology Laboratory has always strived for excel
'"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
18-Jan-2006

Page: 1 2
Related medicine news :

1. New breakthrough treatment for spinal cancer patients at Mount Sinai
2. Mount Sinai and EXACT Sciences announce study results on study stool DNA testing for colon cancer
3. Wiley to assume publication of Mount Sinai Journal of Medicine
4. Mount Sinai researcher finds drinking water safe to drink
5. The Mount Sinai Medical Center recognized for excellence in bariatric surgery
6. Mount Sinai Global Health Center receives $1M grant
7. Mount Sinai School of Medicine receives prestigious AAMC Grant for Chronic Illness Care education
8. Mount Sinai and YAI/NIPD Network join forces to further quality of care for people with autism
9. Mount Sinai launches combination therapy trial to treat Relapsing-Remitting Multiple Sclerosis
10. CNIC commits 5 million Euros to the Mount Sinai School of Medicine
11. Mountain bikers are cautioned to ride with care - major injuries do happen